BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 19444013)

  • 1. HFE-associated hereditary hemochromatosis.
    Alexander J; Kowdley KV
    Genet Med; 2009 May; 11(5):307-13. PubMed ID: 19444013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Molecular genetic diagnostics and screening of hereditary hemochromatosis].
    Zlocha J; Kovács L; Pozgayová S; Kupcová V; Durínová S
    Vnitr Lek; 2006 Jun; 52(6):602-8. PubMed ID: 16871764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hereditary hemochromatosis.
    Crownover BK; Covey CJ
    Am Fam Physician; 2013 Feb; 87(3):183-90. PubMed ID: 23418762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iron-overload-related disease in HFE hereditary hemochromatosis.
    Allen KJ; Gurrin LC; Constantine CC; Osborne NJ; Delatycki MB; Nicoll AJ; McLaren CE; Bahlo M; Nisselle AE; Vulpe CD; Anderson GJ; Southey MC; Giles GG; English DR; Hopper JL; Olynyk JK; Powell LW; Gertig DM
    N Engl J Med; 2008 Jan; 358(3):221-30. PubMed ID: 18199861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hereditary hemochromatosis: insights from the Hemochromatosis and Iron Overload Screening (HEIRS) Study.
    McLaren GD; Gordeuk VR
    Hematology Am Soc Hematol Educ Program; 2009; ():195-206. PubMed ID: 20008199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hereditary hemochromatosis.
    Fix OK; Kowdley KV
    Minerva Med; 2008 Dec; 99(6):605-17. PubMed ID: 19034258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HFE C282Y homozygotes aged 25-29 years at HEIRS Study initial screening.
    Barton JC; Acton RT; Leiendecker-Foster C; Lovato L; Adams PC; McLaren GD; Eckfeldt JH; McLaren CE; Reboussin DM; Gordeuk VR; Speechley MR; Reiss JA; Press RD; Dawkins FW;
    Genet Test; 2007; 11(3):269-75. PubMed ID: 17949288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis and treatment of hereditary hemochromatosis: an update.
    Kanwar P; Kowdley KV
    Expert Rev Gastroenterol Hepatol; 2013 Aug; 7(6):517-30. PubMed ID: 23985001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blunted increase in serum hepcidin as response to oral iron in HFE-hemochromatosis.
    Sangwaiya A; Manglam V; Busbridge M; Thursz M; Arnold J
    Eur J Gastroenterol Hepatol; 2011 Aug; 23(8):721-4. PubMed ID: 21654321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical manifestations of hemochromatosis in HFE C282Y homozygotes identified by screening.
    McLaren GD; McLaren CE; Adams PC; Barton JC; Reboussin DM; Gordeuk VR; Acton RT; Harris EL; Speechley MR; Sholinsky P; Dawkins FW; Snively BM; Vogt TM; Eckfeldt JH;
    Can J Gastroenterol; 2008 Nov; 22(11):923-30. PubMed ID: 19018338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis and management of hereditary hemochromatosis.
    Salgia RJ; Brown K
    Clin Liver Dis; 2015 Feb; 19(1):187-98. PubMed ID: 25454304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology and diagnostic testing for hemochromatosis and iron overload.
    Adams PC
    Int J Lab Hematol; 2015 May; 37 Suppl 1():25-30. PubMed ID: 25976957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased risk of death from iron overload among 422 treated probands with HFE hemochromatosis and serum levels of ferritin greater than 1000 μg/L at diagnosis.
    Barton JC; Barton JC; Acton RT; So J; Chan S; Adams PC
    Clin Gastroenterol Hepatol; 2012 Apr; 10(4):412-6. PubMed ID: 22265917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetics, Genetic Testing, and Management of Hemochromatosis: 15 Years Since Hepcidin.
    Pietrangelo A
    Gastroenterology; 2015 Oct; 149(5):1240-1251.e4. PubMed ID: 26164493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlates of hepcidin and NTBI according to HFE status in patients referred to a liver centre.
    Ryan E; Ryan JD; Russell J; Coughlan B; Tjalsma H; Swinkels DW; Stewart S; Crowe JP
    Acta Haematol; 2015; 133(2):155-61. PubMed ID: 25277871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hereditary hemochromatosis: missed diagnosis or misdiagnosis?
    Cherfane CE; Hollenbeck RD; Go J; Brown KE
    Am J Med; 2013 Nov; 126(11):1010-5. PubMed ID: 24054178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A time course of hepcidin response to iron challenge in patients with HFE and TFR2 hemochromatosis.
    Girelli D; Trombini P; Busti F; Campostrini N; Sandri M; Pelucchi S; Westerman M; Ganz T; Nemeth E; Piperno A; Camaschella C
    Haematologica; 2011 Apr; 96(4):500-6. PubMed ID: 21173098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blunted hepcidin response to oral iron challenge in HFE-related hemochromatosis.
    Piperno A; Girelli D; Nemeth E; Trombini P; Bozzini C; Poggiali E; Phung Y; Ganz T; Camaschella C
    Blood; 2007 Dec; 110(12):4096-100. PubMed ID: 17724144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Constitutive hepcidin expression prevents iron overload in a mouse model of hemochromatosis.
    Nicolas G; Viatte L; Lou DQ; Bennoun M; Beaumont C; Kahn A; Andrews NC; Vaulont S
    Nat Genet; 2003 May; 34(1):97-101. PubMed ID: 12704388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic iron overload: direct HFE (HLA-H) mutation analysis vs quantitative iron assays for the diagnosis of hereditary hemochromatosis.
    Press RD; Flora K; Gross C; Rabkin JM; Corless CL
    Am J Clin Pathol; 1998 May; 109(5):577-84. PubMed ID: 9576576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.